Calico partners with AbbVie to develop a cancer drug
San Francisco Business Times - 19-Oct-2020Ex-Genentech CEO's drug company starts first clinical trial of cancer research
Previously the Live Forever Club — same community, now with a sharper mission for life extension
Biotech and sports business reporter at San Francisco Business Times
Ron Leuty works on biotech and sports business beats for the San Francisco Business Times -- print, online, social media and podcast.
He got bachelors in journalism, History, Urban Politics from Eastern Michigan University.
Specialties:
• Business-to-business coverage
• Sports and sports business
• Startup management (three B2B journals and one daily business section)
Visit website: http://heresron.blogspot.com/
See also
Source of business news & events in the San Francisco area. Part of the American City Business Journals network.
Details last updated 26-Nov-2020
Ex-Genentech CEO's drug company starts first clinical trial of cancer research